康西哥 CNC 深 滬
等待開盤 03-26 09:30:00 美东时间
32.73
-0.250
-0.76%
華盛通- 最 高33.62
- 今 開33.32
- 成交量 762.46万股
- 最 低 31.77
- 昨 收 32.98
- 總市值 161.03亿
- 52周最高 66.03
- 市盈率 靜 --
- 換手率 1.55%
- 52周最低 25.075
- 委 比 10.47%
- 總股本 4.92亿
- 歷史最高 98.53
- 量 比 0.91
- 振 幅 5.61%
- 歷史最低 12.13
- 每 手 1
- 風險率 11.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
HS Chief Counselor Chris Klomp, At STAT News Conference, Says They're Beginning To Read In Pharma Companies On Codifying MFN Pricing
https://www.statnews.com/stat-summit-east/
03-20 03:59
美股周涨跌榜 | 与诺和诺德“世纪大和解”！Hims周内暴涨超57%；PayPay上市两日涨超32%
与诺和诺德“世纪大和解”！Hims周内暴涨超57%；近十年日企赴美最大IPO，PayPay上市两日涨超32%；获英伟达20亿美元投资，Nebius周涨超26%>>
03-14 10:29
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Why Is Centene Stock Falling On Tuesday?
Centene stock falls as the insurer warns ACA membership could drop sharply, reaffirms 2026 earnings per share guidance.
03-11 01:58
Oil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?
U.S. stocks rose broadly on Tuesday as crude oil plunges over 10% on Trump's Iran end-of-war signals. Traders also await Oracle's earnings.
03-11 01:03
Centene drops as CEO cites Obamacare headwinds
Centene (CNC) fell ~11% on Tuesday after the managed care firm's CEO, Sarah London, presented at the Barclays Healthcare Conference, flagging continuing headwinds in its operations in the Affordable C...
03-10 23:14
Centene to reaffirm full-year earnings guidance
Centene (CNC) expects to reaffirm its previously issued earnings guidance for the year as it presents at the Barclays 28th Annual Global Healthcare Conference today. The company expects full-year 2026...
03-10 18:12
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
A Glimpse Into The Expert Outlook On Centene Through 5 Analysts
Centene (NYSE:CNC) underwent analysis by 5 analysts in the last quarter, reveal...
03-05 02:00
